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ABSTACT: Drug-resistant pathogens have risen in frequency and lethality. The development 
of antibiotics with new targets against multi-drug resistant organisms, such as Staphylococcus 
aureus, is imperative. The T-box regulatory mechanism is specific to Gram positive bacteria and 
many operons encoding essential genes required for bacterial growth are controlled by this 
process. The T-box Specifier loop is a novel target for antibacterial drug discovery as we 
hypothesize that a small compound bound to the Specifier loop will inhibit transcription of 
essential bacterial genes resulting in bacterial cell death or growth arrest. Using in silico 
analysis of the T-box Specifier loop, small compounds that are likely to disrupt T-box function 
were identified. Bacterial growth arrest studies identified three initial hit compounds, PKZ 1800, 
PKZ 0600, and PKZ 0700. Both PKZ 1800 and PKZ 0600 demonstrated greater antibacterial 
activity and were pursued for structure activity relationship studies (SAR). SAR was conducted 
with disk diffusion assays against S. aureus with structural analogs of two of our initial hits. 
Results revealed structural components of each hit compound necessary for antibacterial 
activity. Minimum Inhibitory Concentration (MIC) assays and Minimum Bactericidal 
Concentration (MBC) assays were conducted against S. aureus and the Gram-negative 
bacterium Escherichia coli for analogs that displayed antibacterial activity with disc diffusion 
assays. Data from first round SAR studies showed that PKZ 1800 analogs had greater Gram-
positive specificity, making them the focus for second round SAR studies. Using the successful 
compound structures as a template, an additional in silico docking study was conducted on new 
potential analogs containing structures identified as essential to antibiotic activity. Top 
candidates of this docking simulation as well as other carefully selected analogs are currently 
undergoing testing using both MIC and MBC assays to further assess and refine structural 
determinants required for antibacterial activity.  
 
